avelumab
merck,pfizer
['urothelial carcinoma', 'javelin,bladder,100', 'bladder', 'urothelial', 'avelumab']
an exploratory analysis of the javelin bladder 100 study indicated long-term os benefit for patients w/advanced urothelial carcinoma who received avelumab maintenace, w/o regard for treatment given in the second-line setting. #asco22 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.